About Zur Rose Group
Zur Rose Group is a Healthcare company based in Frauenfeld (Switzerland) founded in 1993, and was acquired by PromoFarma in August 2018. Online pharmacy for buying medicines. Zur Rose Group has completed 7 acquisitions, including DocMorris, PromoFarma and Teleclinic. Its chief executive, as recorded, is Matthias Peuckert. Zur Rose Group offers products and services including DocMorris Platform and TeleClinic. Its focus areas include HealthTech, Healthcare Booking Platforms, Pharmacies and Drugs. Its legal entity is DocMorris AG. Its competitors include Apothera, DoryGo and Hydroxychloroquine.
Company details
Zur Rose Group was established in 1993 in Frauenfeld, Switzerland, within the healthcare sector. An online pharmacy is maintained for the purchase of medicines, facilitating direct access for customers. Digital services in drug management are created using AI-based applications to support pharmaceutical processes. Operations are based in Switzerland, emphasizing e-pharmacy solutions and technological integration in healthcare delivery.
- Headquarters Frauenfeld, Switzerland
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website zurrosegroup.com
- Social LinkedIn
- Acquired by PromoFarma (Aug 2018)
- Legal Name Docmorris Ag
- Latest Funding Round$231.29M (USD), Post-IPO
Jul 2020
- Investors
- Investments & AcquisitionsDocMorris
& 6 more
- Acquired byPromoFarma
(Aug 2018)
Products & Services of Zur Rose Group
Zur Rose Group offers a comprehensive portfolio of products and services, including DocMorris Platform and TeleClinic.
Online service for purchasing medications and health products.
Virtual platform for doctor consultations and health advice.
Funding Insights of Zur Rose Group
- Total Rounds 1
- Last Round Post-IPO β $231.29M
- First Round $231.29M
(Jul 2020)
All 1 funding rounds of Zur Rose Group with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2020 | $231.29M | Post-IPO | β | β | β |
1 investors in total: 1 institutional.
Investors in Zur Rose Group
Zur Rose Group has secured backing from 1 investor. Prominent investors backing the company include PromoFarma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Online pharmacy store providing hyper-local delivery | 2012 | promofarma.com | Barcelona, Spain |
Investor details for Zur Rose Group
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Zur Rose Group
1 people are tracked at Zur Rose Group (1 in leadership).
| Name | Role | Group |
|---|---|---|
Matthias Peuckert | CEO | Leadership |
Complete people profiles for Zur Rose Group
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Zur Rose Group
Zur Rose Group has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include DocMorris, PromoFarma and Teleclinic.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Online telemedicine consultations are facilitated via video or phone calls. | teleclinic.com | Munich, Germany | 2015 | Jul 2020 | β’β’β’β’ | |
Medicines for health conditions are sold online by medpex. | medpex.de | Ludwigshafen, Germany | 2005 | Oct 2018 | β’β’β’β’ | |
Online pharmacy store providing hyper-local delivery | promofarma.com | Barcelona, Spain | 2012 | Jul 2018 | β’β’β’β’ | |
Online pharmacy store | apo-rot.de | Hamburg, Germany | 2002 | May 2018 | β’β’β’β’ | |
Medicines for multiple diseases are supplied via an online pharmacy. | eurapon.de | Bremen, Germany | 2006 | Dec 2017 | β’β’β’β’ | |
Prescription drugs and OTC products are ordered online via Vitalsana. | vitalsana.com | Heerlen, Netherlands | 2008 | Nov 2017 | β’β’β’β’ | |
Online pharmacy providing pharmacy products and healthcare services | docmorris.de | Aachen, Germany | 2000 | Oct 2012 | β’β’β’β’ |
Complete acquisition details for Zur Rose Group
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Zur Rose Group
11 dated milestones of Zur Rose Group across 27 years, from founding to its latest funding, stage changes and deals.
- Founded Zur Rose Group is founded.
- Acquisition Acquires DocMorris.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Vitalsana.
- Acquisition Acquires eurapon.
- Acquisition Acquires apo-rot.
- Acquisition Acquires PromoFarma.
- Exit Acquired by PromoFarma.
- Acquisition Acquires medpex.
- Acquisition Acquires Teleclinic.
- Funding First funding round of $231.3M.
Competitors of Zur Rose Group
Zur Rose Group has 3 listed competitors in our database. They include Apothera, DoryGo and Hydroxychloroquine.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| apothera.ch | 2021 | Zug, Switzerland | Prescription drugs for chronic conditions are ordered online by patients. | |||
| dorygo.ch | 2020 | Zurich, Switzerland | Provider of a medication management application for patients | |||
| azhydroxychloroquine.com | 2020 | Bern, Switzerland | An online pharmacy offering comprehensive medication solutions. |
Detailed competitors of Zur Rose Group
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Zur Rose Group
The website of Zur Rose Group (zurrosegroup.com) receives about 1.3K visits a month.
- Monthly visits1.3K
▲ 57.3% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Zur Rose Group
Complete news archive for Zur Rose Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zur Rose Group
Zur Rose Group was founded in 1993 and raised its 1st funding round 27 years after it was founded.
Zur Rose Group is headquartered in Frauenfeld, Switzerland. It is registered at Frauenfeld, Thurgau, Switzerland.
Matthias Peuckert is the CEO of Zur Rose Group, as recorded in our data.
Zur Rose Group was established in 1993 in Frauenfeld, Switzerland, within the healthcare sector. An online pharmacy is maintained for the purchase of medicines, facilitating direct access for customers. Digital services in drug management are created using AI-based applications to support pharmaceutical processes. Operations are based in Switzerland, emphasizing e-pharmacy solutions and technological integration in healthcare delivery.
Zur Rose Group's top competitors include Apothera, DoryGo and Hydroxychloroquine.
Zur Rose Group offers DocMorris Platform and TeleClinic.
Zur Rose Group has made 7 acquisitions, including DocMorris, PromoFarma, and Teleclinic.
Zur Rose Group has 1 investor. Key investors include PromoFarma.
Zur Rose Group operates through Docmorris Ag.
Yes. Zur Rose Group was acquired by PromoFarma in August 2018.

